EPTIS
BAM Logo

Search a Proficiency Testing (PT) scheme in the database

Country
Page 1 of 3 (Hits 1 to 20 of 42)
ID
Country
PT provider
PT scheme
Last changed
925094 United Kingdom UK NEQAS for Microbiology UK NEQAS for Microbiology Molecular detection of SARS-CoV-2 [Molecular detection of SARS-CoV-2] Molecular detection of SARS-CoV-2 [Molecular detection of SARS-CoV-2] 2022-05-13
PT name (Molecular detection of SARS-CoV-2)
Scheme name in national language (Molecular detection of SARS-CoV-2)
Test item (/ absence of SARS-CoV-2 nucleic acid by molecular methods, genotyping of SARS-CoV-2 (if performed))
Tested property (SARS-CoV-2 nucleic acid)

935461 United Kingdom UK NEQAS for Microbiology UK NEQAS for Microbiology SARS-CoV-2 Point of Care [SARS-CoV-2 Point of Care] SARS-CoV-2 Point of Care [SARS-CoV-2 Point of Care] 2023-07-14
PT name (SARS-CoV-2 Point of Care)
Scheme name in national language (SARS-CoV-2 Point of Care)
Tested property (To determine the presence / absence of SARS-CoV-2 antigen/ nucleic acid by point of care devices such as lateral flow, LAMP and antigen test)

699949 United Kingdom UK NEQAS for Immunology, Immunochemistry & Allergy UK NEQAS for Immunology, Immunochemistry & Allergy UK NEQAS for SARS-CoV-2 / COVID-19 Antibodies UK NEQAS for SARS-CoV-2 / COVID-19 Antibodies 2023-05-30
PT name (UK NEQAS for SARS-CoV-2 / COVID-19 Antibodies)
Tested property (SARS-CoV-2 / COVID-19 Antibodies)

824901 Germany Reference Institute for Bioanalytics Reference Institute for Bioanalytics SARS-CoV-2 Immunology [SARS-CoV-2 Immunologie] SARS-CoV-2 Immunology [SARS-CoV-2 Immunologie] 2021-02-16
PT name (SARS-CoV-2 Immunology)
Scheme name in national language (SARS-CoV-2 Immunologie)
Tested property (Anti-SARS-CoV-2 IgG, Anti-SARS-CoV-2 IgA)

794057 Australia RCPAQAP RCPAQAP PHLN: SARS-CoV-2 and other coronaviruses PHLN: SARS-CoV-2 and other coronaviruses 2020-10-23
PT name (PHLN: SARS-CoV-2 and other coronaviruses)
Remarks (Department of Health funded COVID-19 program. Three rounds of this module were offered in 2020 in) (response to the COVID-19 pandemic with plans for another in 2021. This module is suitable for all) (laboratory testing platforms that are utilised in the whole genome sequencing of SARS-CoV-2. Available) (free of charge to Australian public health laboratories that require the capability to test for SARS-CoV-2.)
Tested property (Diluted SARS-CoV-2 (inactivated)) (Diluted SARS-CoV-2 (inactivated))

790376 Australia RCPAQAP RCPAQAP PoCT: COVID-19 serology (IgG/IgM) PoCT: COVID-19 serology (IgG/IgM) 2020-10-26
PT name (PoCT: COVID-19 serology (IgG/IgM))
Tested property (COVID-19 Serology)

789737 Australia RCPAQAP RCPAQAP Molecular Coronavirus SARS-CoV-2 Molecular Coronavirus SARS-CoV-2 2020-10-28
PT name (Molecular Coronavirus SARS-CoV-2)
Tested property (Coronavirus SARS-CoV2)

789879 Australia RCPAQAP RCPAQAP Molecular Respiratory Pathogens Molecular Respiratory Pathogens 2020-10-28
Tested property (Coronavirus (OC43, NL63, SARS-CoV-2))

790103 Australia RCPAQAP RCPAQAP Coronavirus SARS CoV-2 Antibodies Coronavirus SARS CoV-2 Antibodies 2020-10-27
PT name (Coronavirus SARS CoV-2 Antibodies)
Tested property (SARS CoV-2)

807218 Brazil QLM Inovações Tecnológicas QLM Inovações Tecnológicas Interlaboratorial Program Test Mobile Phone [Comparação Interlaboratorial em Ensaio em telefone celular] Interlaboratorial Program Test Mobile Phone [Comparação Interlaboratorial em Ensaio em telefone celular] 2020-11-23
Tested property (SAR)

837442 Brazil PROGRAMA NACIONAL DE CONTROLE DE QUALIDADE PROGRAMA NACIONAL DE CONTROLE DE QUALIDADE COVID-19 (SARS-CoV2) IMUNOCROMATOGRAFIA [COVID-19 (SARS-CoV2) IMUNOCROMATOGRAFIA] COVID-19 (SARS-CoV2) IMUNOCROMATOGRAFIA [COVID-19 (SARS-CoV2) IMUNOCROMATOGRAFIA] 2022-05-30
PT name (COVID-19 (SARS-CoV2) IMUNOCROMATOGRAFIA)
Scheme name in national language (COVID-19 (SARS-CoV2) IMUNOCROMATOGRAFIA)

706310 Portugal Programa Nacional de Avaliação Externa da Qualidade (PNAEQ) INSA DEP UAEQ Programa Nacional de Avaliação Externa da Qualidade (PNAEQ) INSA DEP UAEQ SARS-CoV-2, molecular detection [SARS-CoV-2, molecular detection] SARS-CoV-2, molecular detection [SARS-CoV-2, molecular detection] 2024-03-13
PT name (SARS-CoV-2, molecular detection)
Scheme name in national language (SARS-CoV-2, molecular detection)
Tested property (SARS-CoV-2 virus)

1083473 Brazil METROCERT METROCERT P-021 - Proficiency testing program for Specific Absorption Rate (SAR) testing on a cellular mobile phone [P-021 - Programa de ensaio de proficiência para ensaio de Taxa de Absorção Específica (SAR) em telefone móvel celular] P-021 - Proficiency testing program for Specific Absorption Rate (SAR) testing on a cellular mobile phone [P-021 - Programa de ensaio de proficiência para ensaio de Taxa de Absorção Específica (SAR) em telefone móvel celular] 2023-10-19
PT name (P-021 - Proficiency testing program for Specific Absorption Rate (SAR) testing on a cellular mobile phone)
Scheme name in national language (P-021 - Programa de ensaio de proficiência para ensaio de Taxa de Absorção Específica (SAR) em telefone móvel celular)
Tested property (Specific Absorption Rate (SAR))

134427 United Kingdom LGC AXIO Proficiency Testing LGC AXIO Proficiency Testing Water Microbiology Scheme - (QWAS) Water Microbiology Scheme - (QWAS) 2021-03-01
Tested property (SARS-CoV-2) (Detection of SARS-CoV-2) (Optional quantification of SARS-CoV-2 (Trial))
Testing method (2 x 1.5 ml vial (A & B) of non-infectious, SARS-CoV-2 virus (whole genome) 1 x >100ml sterile water diluent 1 x >20g sterile sludge matrix)

302644 United Kingdom LGC AXIO Proficiency Testing LGC AXIO Proficiency Testing Environmental Hygiene Monitoring Scheme- HYGIENE Environmental Hygiene Monitoring Scheme- HYGIENE 2021-09-06
Test item (Surface testing (swab rinsate) for SARS-CoV-2 molecular)
Tested property (SARS-CoV-2)

769005 United Kingdom LGC AXIO Proficiency Testing LGC AXIO Proficiency Testing SARS-CoV-2 Proficiency Testing Scheme SARS-CoV-2 Proficiency Testing Scheme 2022-05-04
PT name (SARS-CoV-2 Proficiency Testing Scheme)
Test item (SARS-CoV-2 (Serological)- 3 x 0.75 ml samples for detection for the SARS-CoV-2 antibodies -NEW 2020) (SARS-CoV-2 (Molecular)- 2 x 1.5ml samples for SARS-CoV-2 virus -NEW 2020) (SARS-CoV-2 antigen - 3 x swab based samples (A, B, and C). Non-infectious simulated patient) (nasopharyngeal samples containing the SARS-CoV-2 nucleocapsid protein.) (SARS-CoV-2 (Molecular)- 2 x swab based samples. Non-infectious simulated nasopharyngeal samples)
Tested property (SARS-CoV-2 IgA, IgG, IgM, Total antibodies) (SARS-CoV-2 virus) (SARS-CoV-2 virus) (SARS-CoV-2 virus - The samples contain the whole genome) (SARS-CoV-2 virus - The samples contain the whole genome)
Testing method (The samples are derived from naturally occurring material collected via apheresis from patients that have recovered from COVID-19.)

143893 United Kingdom LGC AXIO Proficiency Testing LGC AXIO Proficiency Testing Cosmetics and Toiletries Scheme (COSMETICS) Cosmetics and Toiletries Scheme (COSMETICS) 2023-09-11
Tested property (Relevant to SARS-CoV-2 pandemic)

907768 Germany Institut für Qualitätssicherung Lübeck (IfQ-Lübeck) Institut für Qualitätssicherung Lübeck (IfQ-Lübeck) Antibodies against SARS-CoV-2 [Antikörper gegen SARS-CoV-2] Antibodies against SARS-CoV-2 [Antikörper gegen SARS-CoV-2] 2021-11-25
PT name (Antibodies against SARS-CoV-2)
Scheme name in national language (Antikörper gegen SARS-CoV-2)
Tested property (Anti-SARS-CoV-2 (NCP) IgG) (Anti-SARS-CoV-2 (S1) IgG)

1163321 Germany INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories Virus Genome Detection – Respiratory Virus Panel 2 for Multiplex Tests (432) [Virusgenom-Nachweis - Respiratorisches Virus-Panel 2 für Multiplex Teste (432)] Virus Genome Detection – Respiratory Virus Panel 2 for Multiplex Tests (432) [Virusgenom-Nachweis - Respiratorisches Virus-Panel 2 für Multiplex Teste (432)] 2024-04-16
Tested property (influenza A and B viruses incl. avian influenza A viruses, respiratory syncytial viruses (groups A and B) and SARS-CoV-2 (inactivated))

1163338 Germany INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories Virus Genome Detection – SARS-CoV-2 (409) [Virusgenom-Nachweis - SARS-CoV-2 (409)] Virus Genome Detection – SARS-CoV-2 (409) [Virusgenom-Nachweis - SARS-CoV-2 (409)] 2024-04-16
PT name (Virus Genome Detection – SARS-CoV-2 (409))
Scheme name in national language (Virusgenom-Nachweis - SARS-CoV-2 (409))
Tested property (The sample set contains defined samples with SARS-CoV-2 (full virus, inactivated) and, if necessary) (Polymerase chain reaction (PCR) and other nucleic acid amplification techniques (NAT) for SARS-CoV-2)

Page 1 of 3 (Hits 1 to 20 of 42)
Any questions or problems? Please contact us at eptis@bam.de.
Application version: 1.23-SNAPSHOT.20230502124635-7925ae379a631fc1ececff45d2921c8db38877d5